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Background
CD8+ T-lymphocytes suppress HIV-1 replication through
unknown factors that inhibit HIV-1 transcription initia-
tion. Understanding the regulation of these CD8+ T cell
derived factors can provide important insights into how to
elicit these factors with a vaccine. For a small subset of
human genes, histone deacetylases (HDACs) are epige-
netic regulators that condense chromatin to repress tran-
scription. We examined an HDAC inhibitor's ability to
modulate the expression of suppressive factors from pri-
mary CD8+ T cells from HIV-1+ subjects controlling virus
infection.
Methods
CD4+-enriched PBMC from seronegative donors were
infected with HIV-1NL4-3  pseudotyped reporter virus.
Infected cells were cultured in direct contact or in a tran-
swell system with CD8+ T-lymphocytes from HIV-1+ viral
controllers. HIV-1 suppression was determined in the
absence and presence of an HDAC inhibitor that targets
HDACs 1–5 and 7–9 using an LTR-driven luciferase
reporter.
Results
HIV-1 suppression by primary CD8+ T-lymphocytes from
HIV-1+ viral controllers was reversed up to 40% by the
addition of an HDAC inhibitor. Virus suppression by
HVS-transformed CD8+ T-lymphocytes was inhibited by
45% in the presence of an HDAC inhibitor. The portion
of the overall suppressive activity mediated by soluble fac-
tors was completely reversed by the HDAC inhibitor. Pre-
incubation of HVS-transformed or primary CD8+ T-lym-
phocytes by the HDAC inhibitor decreased their subse-
quent suppressive ability by 3.5 and 2.4-fold respectively.
Conclusion
Blocking HDACs impairs the ability of CD8+  T-lym-
phocytes to repress HIV-1 transcription; suggesting the
expression of the suppressive factors is regulated by epige-
netics. With 2–5% of genes being regulated by HDAC, our
data provides a way to focus the search for the suppressive
factors. The ability to modulate expression of the suppres-
sive factors can facilitate their identification and aid in
determining how to elicit these factors with a HIV-1 vac-
cine.
from AIDS Vaccine 2009
Paris, France. 19–22 October 2009
Published: 22 October 2009
Retrovirology 2009, 6(Suppl 3):P269 doi:10.1186/1742-4690-6-S3-P269
<supplement> <title> <p>AIDS Vaccine 2009</p> </title> <editor>Anna Laura Ross</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1742-4690-6-S3-full.pdf">here</a>.</note> <url>http://www.biomedcentral.com/content/pdf/1471-2105-10-S12-info.pdf</url> </supplement>
This abstract is available from: http://www.retrovirology.com/content/6/S3/P269
© 2009 Saunders et al; licensee BioMed Central Ltd. 